Prospective pilot study to determine if changing the phosphate binder to sucroferric oxyhydroxide for for 6 months improves disordered mineral metabolism and nutrition status in peritoneal dialysis patients.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
17
Patients will be started on 1 tablet three times daily with meals and the dose will be titrated monthly in increments of 500mg (1 tablet) per day until serum phosphate is at goal
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Serum Phosphate at Baseline
Serum phosphate at baseline
Time frame: Baseline
Serum Phosphate at 6 Months
Serum phosphate at end of study (6 months)
Time frame: 6 months
Serum Albumin
Changes in serum albumin from baseline to 6 months
Time frame: Baseline, 6 months
Serum FGF23
Change in serum FGF23 from baseline to 6 months
Time frame: 6 months
Serum PTH
Change in serum PTH (perathyroid hormone) from baseline to 6 months
Time frame: Baseline, 6 months
Serum Prealbumin
Change in prealbumin from baseline to 6 months
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.